The Associated Press on MSN13d
EU Commission fines Teva $500 million for trying to stop rival’s multiple sclerosis drug
The European Commission has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly ...
The Mirror5d
Lupus cure could be on the horizon as 'groundbreaking' autoimmune drug starts trials
A "groundbreaking" drug is being trialled in the first Brits to cure autoimmune conditions such as lupus and multiple ...
Teva Fined Around $500 Million by EU Over MS Drug Competition Concerns
Teva Fined Around $500 Million by EU Over MS Drug Competition Concerns ...
McKnight's Long-Term Care News12d
Report: Parkinson’s, Alzheimer’s drug costs soared over nearly decade; MS meds rose most
People with multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, and that amount soared to $2,378 annually in 2021, according to a new study. The study  examined the ...
U.S. News & World Report13d
EU Commission Fines Teva $500 Million for Trying to Stop Rival's Multiple Sclerosis Drug
EU Commission Fines Teva $500 Million for Trying to Stop Rival's Multiple Sclerosis Drug BRUSSELS (AP) — The European Commission said Thursday it has fined Israeli generic drugmaker Teva more ...
Atlanta Journal-Constitution13d
EU Commission fines Teva $500 million for trying to stop rival's multiple sclerosis drug
for improperly seeking to protect the patent for its multiple sclerosis drug and for disparaging a rival company's development of a competing medicine. The commission said the pharmaceutical firm ...
Daily Journal13d
EU Commission fines Teva $500 million for trying to stop rival’s multiple sclerosis drug
for improperly seeking to protect the patent for its multiple sclerosis drug and for disparaging a rival company’s development of a competing medicine. The commission said the pharmaceutical ...